Neuronasal

Neuronasal develops drugs, delivered intranasally, for acute brain injuries. Our 1st products are for concussion and are safe, repurposed drugs.

  • Stage Product In Development
  • Industry Biotechnology
  • Location New York, NY, US
  • Currency USD
  • Founded May 2014
  • Employees 0
  • Incorporation Type LLC
  • Website synaptic.bio

Company Summary

Neuronasal was founded to create value for patients and investors by in-licensing and developing drugs to treat acute brain injuries and disease. We plan to develop each of our drugs to proof-of-concept and then enter into strategic partnerships or trade sales.

The company's initial intellectual property was licensed from HealthPartners of Minneapolis and from Cornell University.

Team

  • Thomas Bradshaw
    CEO, Co-Founder

    • Ricerca Biosciences - bought Ricerca when it was a small contract agricultural research company and turned it into a contract drug discovery/development company serving most of the biotech industry; sold to SV Life/Bain 2007

    • Co-founder, Devirex Pharmaceuticals - commercial herpes prevention product marketed in EU

    • Co-founder, Great Lakes Pharmaceuticals

    • Co-founder and chairman, Buckeye Pharmaceuticals

  • Daniel P. van Kammen, MD, PhD, FACNP, FAPA
    Chief Medical Officer and Regulatory Affairs

    • Acadia Pharmaceuticals, Vice President of Clinical Development

    • Aventis, Head of CNS, Clinical Discovery and Human Pharmacology and co-responsible for Aventis' schizophrenia strategy

    •  J&J Pharmaceutical Research and Development, Senior Director of Global Development, CNS strategy and program development

  • Michael G Lanzilotti
    Vice President of Operations

    •  Pharmaceutical & device executive; 25+ years leading teams to conceptualize, design, develop, commercialize drug /device products.
    •  Expert in delivery systems; co-author of numerous publications and 10 patents (7 commercialized). Versed in VC funded start-ups.
    •  VP Product Development & Manufacturing Great Lakes Pharmaceuticals.
    •  EVP & COO Oakwood Laboratories.
    •  Inventorship led to creation of J&J’s OraPharma, Inc. and of Arestin®

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free